Morgan Stanley disclosed exposure to XRP (XRP) through three ETFs while the token struggles near $1 after losing more than 10% this week and almost 70% in 2026.
Key Points:
- Q2 filings showed Morgan Stanley exposure through three XRP-linked funds.
- Other investment managers also reported XRP ETF holdings despite the token’s steep 2026 decline.
- A 0.86 Taker Buy/Sell Ratio and elevated futures open interest point to continued downside risk.
XRP ETF Holdings
Morgan Stanley’s Q2 2026 Form 13F showed positions in three XRP-linked ETFs: 6,715 shares of Franklin’s fund, 255 shares of REX-Osprey’s ETF and 67 shares of Bitwise’s ETF. A larger position appeared in Armada Acquisition Corp II, Ripple-backed Evernorth Holdings’ SPAC partner.
Other investment firms reported larger positions in XRP products. Wolverine Asset Management held 199,912 shares of the Bitwise XRP ETF, while Gallacher Capital Management reported 86,744 shares of Canary’s fund and Main Street Group held 5,261 shares of the same product.
Moisand Fitzgerald Tamayo held 964 Franklin XRP ETF shares, while National Bank of Canada disclosed 3,848 shares of Bitwise’s XRP fund.





